Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 27, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for June 24, 2006 Subscribe to this News Feed      
 

International Academy of Life Sciences Applauds Novel Product for Diarrhea

New Study Finds Ventria Bioscience’s Oral Rehydration Solution is Effective Against the Number Two Infectious Killer of Children

Hanover, Germany (PRWEB) June 24, 2006 -- A new approach to fighting diarrhea that fortifies the standard product, oral rehydration solution, with two key protective breast milk proteins is a revolutionary development that could save the lives of millions of children around the world, the head of an international group of medical and academic researchers said today.

The proteins were developed by U.S.-based Ventria Bioscience, which through a plant-based system is able to cost-efficiently produce significant quantities of lactoferrin and lysozyme, two proteins found naturally in breast milk.

This innovative science promises to provide new solutions to a long-standing public health problem. We applaud this effort.
“Our academic community supports the development of plant-made pharmaceuticals because of their tremendous potential to treat life-threatening illness,” said Hilmar Stolte, M.D., president of the International Academy of Life Sciences (IALS). “Now we have a study that provides tangible proof of what is possible with this technology.”

Diarrhea is the number-two infectious killer of children under five in the world and its effects are particularly acute in developing countries such as Peru, where more than 20 percent of the 36,000 children who die every year are victims of diarrhea.

A study conducted by investigators in the US and Peru found that by adding Ventria’s proteins to the standard treatment for diarrhea, oral rehydration solution, both the length and the severity of diarrhea decreased.
      
The study, which was conducted following World Health Organization protocols, found that children consuming oral rehydration solution with lactoferrin and lysozyme were sick for 3.67 days on average, as compared to 5.21 days for children receiving oral rehydration solution without the added proteins. Children receiving the enhanced oral rehydration solution had 30 percent shorter duration of the diarrhea. In addition, the children who received Ventria’s proteins had a higher rate of recovery and reduced incidence of another episode of diarrhea.
   
Leading researchers in the field have said that the development is a significant breakthrough in a condition that kills more than 2 million children every year.
   
“We know that babies that drink breast milk do not get diarrhea with anywhere near the same frequency as children who are not breast fed, so if you can take the important components of breast milk and extend them to children who are not breastfeeding and older people this would be a huge advantage,” William Greenough III, MD, professor of medicine at Johns Hopkins University and an international expert in pediatric and geriatric diarrhea, has said. “This is what we call the Holy Grail: We’d like to have something that both hydrated people and could shorten the illness.”

According to the World Health Organization there are 4 billion episodes of diarrhea in children each year. Many of these are repeat instances that can create chronic health problems including malnutrition, which in turn can weaken children’s immune systems and expose them to additional health risks such as infection, pneumonia and anemia.

“Diarrhea is a dreadful disease that preys worldwide upon the most innocent and the most vulnerable groups of people: children, the elderly and the poor,” Dr. Stolte said. “This innovative science promises to provide new solutions to a long-standing public health problem. We applaud this effort.”

Stolte, IALS and its U.S. partner, the Biomedical Exchange Program (BMEP), host http://www.plantpharma.org, an online community dedicated to a science-based, medically oriented discussion on PMPs and their potential to help combat life-threatening illness.

IALS is a global network of universities, medical schools, and related institutions that are dedicated to education, training and research in key issues associated with the life sciences.

Resources:    
http://www.plantpharma.org
http://www.ventria.com
http://www.lifesciences.net
WHO guidelines on treatment of diarrhea: http://www.who.int/child-adolescent-health/publications/referral_care/chap4/chap41.htm

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1Mb3ZlLVRoaXItQ291cC1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Sarah Fuhrmann
for the International Academy of Life Sciences
877-835-8362
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright